Astec Lifesciences Ltd
₹623.70
(-0.66%)
Wed, 04 Mar 2026, 00:27 am
Process Industries
Chemicals: Agricultural
24.5KAstec Lifesciences Price to Cash Flow Ratio
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 4.47 | 15.92 | 36.30 | 4.93 | 7.85 | 19.38 | 76.77 | 61.70 | 32.61 | 29.50 | 16.48 | 30.12 | 38.22 | 106.03 | 0 | 0 |
| Price to book ratio | 0 | 0.89 | 0.80 | 0.51 | 0.29 | 0.60 | 2.11 | 3.21 | 8.53 | 6.70 | 5.20 | 3.17 | 6.34 | 8.66 | 6.46 | 5.64 | 5.64 |
| Price to sales ratio | 0 | 0.53 | 0.71 | 0.44 | 0.17 | 0.33 | 1.08 | 1.66 | 4 | 3.15 | 2.45 | 1.50 | 3.53 | 5.08 | 4.32 | 4.54 | 3.48 |
| Price to cash flow ratio | 0 | 8.73 | 5.57 | 10.58 | 2.83 | 6.67 | 47.32 | 0 | 159.69 | 20.87 | 322.19 | 5.03 | 0 | 228.64 | 46.20 | 0 | 0 |
| Enterprise value | 0 | 941.03M | 1.19B | 1.06B | 938.55M | 1.46B | 3.73B | 5.01B | 13.01B | 12.61B | 12.29B | 8.8B | 21.45B | 37.12B | 30.5B | 25.74B | 18.75B |
| Enterprise value to EBITDA ratio | 0 | 3.69 | 7.55 | 6.27 | 3.26 | 3.95 | 6.84 | 14.54 | 20.72 | 20.02 | 15.60 | 10.18 | 19.04 | 23.88 | 38.77 | 0 | 0 |
| Debt to equity ratio | 1.36 | 0.40 | 0.45 | 0.73 | 0.66 | 0.73 | 0.73 | 1.08 | 0.92 | 0.73 | 0.87 | 0.40 | 0.61 | 0.70 | 0.81 | 1.34 | 2.36 |
| Return on equity % | 0 | 21.11 | 5.17 | 1.40 | 5.83 | 7.91 | 11.88 | 3.92 | 15 | 22.69 | 19.21 | 21.16 | 23.41 | 25.47 | 6.26 | -11.89 | -44.61 |
Astec Lifesciences Ltd Price to Cash Flow Ratio
The Astec Lifesciences Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Astec Lifesciences Ltd's valuation, profitability, and overall financial performance. Tracking the Astec Lifesciences Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Astec Lifesciences Ltd (NSE: ASTEC, BSE: 533138) is currently trading at ₹623.70, with a market capitalization of ₹13.9B. As a leading company in the Process industries sector and Chemicals: agricultural industry, monitoring the Astec Lifesciences Ltd Price to Cash Flow Ratio is essential for fundamental analysis.
Astec Lifesciences Ltd Price to Cash Flow Ratio Current Value
The current Astec Lifesciences Ltd Price to Cash Flow Ratio stands at 0.
The Astec Lifesciences Ltd Price to Cash Flow Ratio remains stable, indicating consistent financial performance.
Astec Lifesciences Ltd Price to Cash Flow Ratio Historical Trend
The Astec Lifesciences Ltd Price to Cash Flow Ratio has shown the following historical trend:
- 2024: 0
- 2023: 0
- 2022: 46.20
- 2021: 228.64
- 2020: 0
The decline in Astec Lifesciences Ltd Price to Cash Flow Ratio indicates improving financial efficiency or better earnings growth.
What Astec Lifesciences Ltd Price to Cash Flow Ratio Indicates for Investors
The Astec Lifesciences Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/CF ratio indicates how much investors pay for company cash flow.
Astec Lifesciences Ltd Price to Cash Flow Ratio Analysis Summary
The Astec Lifesciences Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Astec Lifesciences Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Astec Lifesciences Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800